These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Synthesis and clinical application of representative small-molecule dipeptidyl Peptidase-4 (DPP-4) inhibitors for the treatment of type 2 diabetes mellitus (T2DM). Shao DW, Zhao LJ, Sun JF. Eur J Med Chem; 2024 Jun 05; 272():116464. PubMed ID: 38704940 [Abstract] [Full Text] [Related]
27. Synthesis and biological evaluation of azobicyclo[3.3.0] octane derivatives as dipeptidyl peptidase 4 inhibitors for the treatment of type 2 diabetes. Cho TP, Long YF, Gang LZ, Yang W, Jun LH, Yuan SG, Hong FJ, Lin W, Liang GD, Lei Z, Jing LJ, Shen GA, Hong SG, Dan W, Ying F, Ke YP, Ying L, Jun F, Tai MX. Bioorg Med Chem Lett; 2010 Jun 15; 20(12):3565-8. PubMed ID: 20488702 [Abstract] [Full Text] [Related]
29. Antidiabetic activity of Commiphora mukul and Phyllanthus emblica and Computational analysis for the identification of active principles with dipeptidyl peptidase IV inhibitory activity. Mohanty IR, Kumar CS, Borde M. Indian J Pharmacol; 2021 Jun 15; 53(5):384-387. PubMed ID: 34854407 [Abstract] [Full Text] [Related]
30. Design, synthesis, biological screening, and molecular docking studies of piperazine-derived constrained inhibitors of DPP-IV for the treatment of type 2 diabetes. Kushwaha RN, Srivastava R, Mishra A, Rawat AK, Srivastava AK, Haq W, Katti SB. Chem Biol Drug Des; 2015 Apr 15; 85(4):439-46. PubMed ID: 25216392 [Abstract] [Full Text] [Related]
33. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2 Diabetes mellitus Predicted by 3D QSAR Pharmacophore Models, Molecular Docking and de novo Evolution. Musoev A, Numonov S, You Z, Gao H. Molecules; 2019 Aug 07; 24(16):. PubMed ID: 31394858 [Abstract] [Full Text] [Related]
34. The optimization of xanthine derivatives leading to HBK001 hydrochloride as a potent dual ligand targeting DPP-IV and GPR119. Li G, Meng B, Yuan B, Huan Y, Zhou T, Jiang Q, Lei L, Sheng L, Wang W, Gong N, Lu Y, Ma C, Li Y, Shen Z, Huang H. Eur J Med Chem; 2020 Feb 15; 188():112017. PubMed ID: 31926470 [Abstract] [Full Text] [Related]
39. Synthesis, nitric oxide release, and dipeptidyl peptidase-4 inhibition of sitagliptin derivatives as new multifunctional antidiabetic agents. Xie Y, Shao L, Wang Q, Bai Y, Chen Z, Li N, Xu Y, Li Y, Yang G, Bian X. Bioorg Med Chem Lett; 2018 Dec 15; 28(23-24):3731-3735. PubMed ID: 30343953 [Abstract] [Full Text] [Related]
40. Discovery and Rational Design of Natural-Product-Derived 2-Phenyl-3,4-dihydro-2H-benzo[f]chromen-3-amine Analogs as Novel and Potent Dipeptidyl Peptidase 4 (DPP-4) Inhibitors for the Treatment of Type 2 Diabetes. Li S, Xu H, Cui S, Wu F, Zhang Y, Su M, Gong Y, Qiu S, Jiao Q, Qin C, Shan J, Zhang M, Wang J, Yin Q, Xu M, Liu X, Wang R, Zhu L, Li J, Xu Y, Jiang H, Zhao Z, Li J, Li H. J Med Chem; 2016 Jul 28; 59(14):6772-90. PubMed ID: 27396490 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]